To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

May 5, 2022

Study Completion Date

May 5, 2022

Conditions
Irritable Bowel Syndrome With Diarrhea
Interventions
OTHER

Group I: L. plantarum UALp-05TM,

One capsule to be taken orally before lunch with a glass of water. In case the dose is missed, advise participant to take before dinner.

OTHER

Group II: L. plantarum UALp-05TM,

One capsule to be taken orally before lunch with a glass of water. In case the dose is missed, advise participant to take before dinner.

OTHER

Microcrystalline cellulose

One capsule to be taken orally before lunch with a glass of water. In case the dose is missed, advise participant to take before dinner.

Trial Locations (12)

221010

Khannas Clinic, Varanasi

380054

SN Gastro and Liver Clinic, Ahmedabad

380061

Ahmedabad Gastro Associates,, Ahmedabad

400059

Dr. Khanna Clinic,, Mumbai

Stress Test Clinic, Mumbai

421004

Ashirwad Hospital And Research Centre,, Ulhasnagar

380013.

Apex Gastro Clinic and Hospital,, Ahmedabad

-390021.

Aman Hospital and research center, Vadodara

400059.

My Health Clinic,, Mumbai

400705,

Samarth Digestive Disease Centre, Mumbai

440008.

Rahate Surgical Hospital,, Nagpur

221005.

Shubham Sudbhawana Superspeciality Hospital,, Varanasi

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT04950296 - To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter